May 24, 2024
Company to watch: Salfarm, a portfolio firm of Dansk Ejerkapital specializing in production and distribution of veterinary vaccines, medicine, and other equipment, expects steady growth to reach EBITDA of DKK +40m in FY24E (NKP Proprietary)
NKP | M&A Insights Proprietary
Headline from pre-deal coverage in M&A Insights